Patient Rating:

No Rating Available?

Anupam R. Verma, M.D.

Patient Rating:

No Rating Available?

Specialties

Languages

  • English
  • Hindi

Clinical Details

Phone Number Clinical Office Address
Primary Children's Hospital
Pediatric Hematology/Oncology
100 N Mario Capecchi Drive
Salt Lake City, UT 84113
(801) 662-4700
Primary Children's Hospital
100 N Mario Capecchi Drive
Salt Lake City, UT 84113

Bio

Anupam Verma, MD, is an assistant professor and physician in the Division of Pediatric Hematology and Oncology at the University of Utah, an investigator at the Huntsman Cancer Institute (HCI), and a member of the Experimental Therapeutics program. In her clinical work at Primary Children’s Medical Center, she cares for children with blood diseases and cancers.

As a researcher, Verma is involved in developing and conducting early phase clinical trials for children with leukemia and lymphomas. At HCI, her research focus is novel target drug development to advance cures for pediatric cancer.

Verma is board-certified in pediatrics and recently completed a fellowship in pediatric hematology and oncology at the University of Utah and Primary Children’s Medical Center. She has been an assistant professor of pediatrics at the University of Utah School of Medicine since 2009. Verma completed her pediatric residency at Brookdale University Hospital and Medical Center in Brooklyn, New York. She worked as a senior resident doctor in pediatrics at All India Institute of Medical Sciences in New Delhi, India. She received her medical degree and her doctorate in pediatrics from Baroda Medical College, India.

Board Certification and Academic Information

Academic Departments Pediatrics - Assistant Professor (Clinical)
Academic Divisions Pediatric Hematology/Oncology
Board Certification American Board of Pediatrics (Pediatrics)
Indian Board of Pediatrics
American Board of Pediatrics (Sub: Ped Hematology-Oncology)

Academic Profile

Board Certification and Academic Information

Academic Departments Pediatrics - Assistant Professor (Clinical)
Academic Divisions Pediatric Hematology/Oncology
Board Certification American Board of Pediatrics (Pediatrics)
Indian Board of Pediatrics
American Board of Pediatrics (Sub: Ped Hematology-Oncology)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 662-1000 Primary Children's Hospital
100 N Mario Capecchi Drive
Salt Lake City, UT 84113

Academic Bio

Anupam Verma, MD, is an assistant professor and physician in the Division of Pediatric Hematology and Oncology at the University of Utah, and an investigator at the Huntsman Cancer Institute (HCI), and a member of the Experimental Therapeutics program. In her clinical work at Primary Children’s Medical Center, she cares for children with blood diseases and cancers.

As a researcher, Verma is involved in developing and conducting early phase clinical trials for children with leukemia and lymphomas. At HCI, her research focus is novel target drug development to advance cures for pediatric cancer.

Verma is board-certified in pediatrics and recently completed a fellowship in pediatric hematology and oncology at the University of Utah and Primary Children’s Medical Center. She has been an assistant professor of pediatrics at the University of Utah School of Medicine since 2009. Verma completed her pediatric residency at Brookdale University Hospital and Medical Center in Brooklyn, New York. She worked as a senior resident doctor in pediatrics at All India Institute of Medical Sciences in New Delhi, India. She received her medical degree and her doctorate in pediatrics from Baroda Medical College, India.

Education

Education History

Type School Degree
Fellowship University of Utah
Pediatric Hematology/Oncology
Fellow
Chief Resident Brookdale University Hospital Medical Center
Pediatrics
Chief Resident
Residency Brookdale University Hospital Medical Center
Pediatrics
Resident
Residency University of Baroda Medical College
Pediatrics
Resident
Professional Medical University of Baroda Medical College
Medicine
M.B.B.S.

Publications

Selected Provider Publications

Journal Article

  1. Raffaella Soldi, Stephen K Horrigan, Marek W Cholody, Janak Padia, Venkataswamy Sorna, Jared Bearss, Glynn Gilcrease, Kapil Bhalla, Anupam Verma, Hariprasad Vankayalapati, and Sunil Sharma (7/16/2015). Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors. J Med Chem.
  2. Mangum DS1, Verma A, Weng C, Sheng X, Larsen R, Kirchhoff AC, Druzgal C, Fluchel M (November, 2013). A comparison of central lines in pediatric oncology patients: Early removal and patient centered outcomes. Pediatr Blood Cancer.
  3. Mollard A, Warner SL, Call LT, Wade ML, Bearss JJ, Verma A, Sharma S, Vankayalapati H, Bearss DJ (12/08/2011). Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors. ACS Medicinal Chemistry Letters, 2(12), 901-912.
  4. Verma A, Zhou H, Chin S, Bruggers C, Kestle J, Khatua S (12/20/2011). EGFR as a predictor of relapse in myxopapillary ependymoma. Pediatr Blood Cancer.
  5. Everitt MD, Verma AR, Saarel EV (Sept 2011). The wearable external cardiac defibrillator for cancer patients at risk for sudden cardiac death. Community Oncology, 8(9), 400-403.
  6. Verma AR, OP Shukla (2004). Usher's Syndrome. Indian Journal of Otolaryngology and Head and Neck Surgery, 56, 119-121.

Review

  1. Glade Bender J, Verma A, Schiffman JD (February, 2015). Translating genomic discoveries to the clinic in pediatric oncology. [Review]. Current Opinion in Pediatrics.
  2. Verma A, Warner SL, Vankayalapati H, Bearss DJ, Sharma S (09/20/2011). Targeting Axl and Mer Kinases in Cancer. [Review]. Molecular Cancer Therapeutics, (Oct 2011), 1763-73.

Letter

  1. Mollard A, Warner SL, Call L, Wade M, Bearss J, Verma AR, Sharma S, Bearss DJ, Vankayalapati H (April 2011). Homology structure-based design, synthesis and biological evaluation of a series of novel Axl and Mer kinase Inhibitors [Letter to the editor]. ACS Med Chem Lett, 12(2), 907-912.

Abstract

  1. Anupam Verma, Zachery Halford, Megan Corsi, Debra Beckstrom (12/3/2015). Retrospective Analysis of Clinical Response in Children with Severe Immune Thrombocytopenia Undergoing Treatment with Intravenous Immune Globulin [Abstract]. Blood, 126(23), 4652.
  2. Anupam Verma, Lauri Linder, Elizabeth D Knackstedt, Cheryl Gerdy, Rouett Abouzelof, Richard S Lemons (12/7/2105). Reduction in Inpatient Central Line Associated Blood Stream Infection Post Implementation of Bundled Care Measures in Patients with Benign and Malignant Hematological Conditions in a Single Pediatric Institution [Abstract]. Blood.
  3. Weili Sun, Jemily Malvar, Richard Sposto, Anupam Verma, Jennifer J Wilkes, Robyn M Dennis, Kenneth Matthew Heym, Elena Eckroth, Jeannette Vandergiesse, Paul S Gaynon, Alan S Wayne, James A Whitlock (12/7/2015). Re-Induction Outcome for Pediatric Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Therapeutic Advances in Childhood Leukemia Consortium [Abstract]. Blood.
  4. A Ast, A Putnam, J Schiffman, A Hill, E Perlman, S South, C Paxton, A Verma (May, 2015). DICER1 showing its ugly face again. A novel DICER1 mutation identified in a female with an undifferentiated renal sarcoma with cystic nephroma background [Abstract]. Pediatric Blood & Cancer.
  5. Michael J Burke, Patrick Brown, Lia Gore, Richard Sposto, Deepa Bhojwani, Bill H Chang, Steven G Dubois, Paul S Gaynon, Julia Glade-Bender, Kenneth Matthew Heym, Maria Luisa Sulis, Jessica A Pollard, Anupam Verma, and Van Huynh (12/6/2014). Invasive Candida Infections in Pediatric Patients Treated on the Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium [Abstract]. Blood, 124(21), 3650.
  6. Verma A, Frazer JK, Trakhimets A, Heaton W, Bearrs J, Warner S, Bearrs D, Sharma S (Dec 2011). A Novel Dual AXL/Mertk and Aurora Kinase Inhibiton Active Against T Cell Acute Lymphoblastic Leukemia [Abstract]. Blood, 118, 1519.
  7. Verma AR, Fluchel M, Barnette P (Oct 18-20, 2011). Familial Hemophagocytic Lymphohistiocytosis presenting with Nonimmune Hydrops Fetalis [Abstract]. Blood, 56(4), 701.
  8. Verma AR, Rodgers G, Yaish H (Dec 3-7, 2010). Type 3 Von Willebrand Disease with Alloantibodies and Its Challenging Management During Episode of Bleeding [Abstract]. Blood.
  9. Verma A, Zhou H, Chin S, Bruggers C, Kestle J, Khatua S (Nov 18-21, 2010). EGFR as a predictor of relapse and a potential therapeutic target in recurrent disseminated myxopapillary ependymoma [Abstract]. Pediatric Blood & Cancer.
  10. Mangum DS, Verma AR, Druzgal C, Larsen R, Fluchel M (04/08/2010). External Venous Catheters Have a Higher Rate of Early Removal than Subcutaneous Ports in Pediatric Cancer Patients [Abstract]. Pediatric Blood & Cancer.
  11. Verma AR, Mangum DS, Druzgal C, Owen C, Collingridge D, Fluchel M (04/09/2010). Subcutaneous Ports Versus External Venous Catheters from the Perspective of Pediatric Oncology Patients and their Families [Abstract]. Pediatric Blood and Cancer.

Poster

  1. Jessica Meznarich, Anupam Verma (05/13/2016). Cytomegalovirus retinitis diagnosed by vitreous aspiration in a patient with T-cell acute lymphoblastic Leukemia. Poster session presented at ASPHO, Minneapolis.

Clinical Trials

Clinical Trials

Video & News